Hansa Biopharma — Major Shareholding Notification 2016

Mar 9, 2016

Issuer Hansa Biopharma AB

Holder

Farstorps Gård AB

Instrument

Instrument	Ordinary shares SE0002148817
Before the transaction
Shares	Data not given*
Voting rights	Data not given*
Transaction
Reason for major shareholding notification Sell
Date	08/03/2016
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	1,084,070
Directly held voting rights	1,084,070
Indirectly held voting rights	0
Percentage
Directly held shares	3.345 %
Directly held voting rights	3.345 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	3.345 %	1,084,070
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3	0.123 %	40,000
- Physically settled - Cash settled
Total	3.468 %	1,124,070
Group total holdings Voting rights
1,124,070 Percentage of voting rights 3.468
Published 09/03/2016 17:20
Contact
Name Tove Håkansson
Phone 0706777275 Email hannes.mellberg@fredersen.se
*Source of information has chosen not to submit the data

CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25